skip to content
Primary navigation


Drug - Jublia® (efinazonazole solution) [Valeant Pharmaceuticals North America LLC]

November 2014

Therapeutic area - Onychomycosis

Approval criteria

  • Patient has a diagnosis of onychomycosis of the toenails AND
  • Patient has tried and failed a 48 week course of ciclopirox AND
  • Patient has a contraindication or intolerance to oral itraconazole or terbinafine


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top